Fluarix Tetra

Fluarix Tetra is an influenza vaccine designed to protect against four strains of the flu virus. This vaccine is administered intramuscularly and is manufactured by Glaxosmithkline Biologicals S.A. in the EU.

Fluarix Tetra is used to prevent influenza caused by the B/Phuket/3073/2013-like virus and the Influenza Virus B/Austria/1359417/2020. It is typically administered annually to help reduce the risk of flu infection and its complications. This vaccine is often recommended for individuals who are at higher risk of severe flu symptoms or complications.

Common effects of Fluarix Tetra may include soreness, redness, or swelling at the injection site. Some individuals may also experience mild fever, headache, or muscle aches following vaccination. These effects are usually temporary and resolve on their own within a few days.

Fluarix Tetra should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to previous influenza vaccines or any of its components should avoid this vaccine. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine.

Fluarix Tetra may interact with certain medications or other vaccines. It is advisable to discuss your current medications and vaccination schedule with a healthcare professional before receiving this vaccine. Alcohol and other substances should be discussed with a healthcare provider to ensure safety.